Samsung has started rolling out its long awaited blood pressure monitoring feature for Galaxy Watch owners in the United States. The wellness feature, available through the Samsung Health Monitor app, works on compatible watches from the Galaxy Watch 4 onward and requires periodic calibration with a traditional upper arm cuff.
Glimpse:
Announced on March 31, 2026, the phased rollout makes blood pressure tracking accessible to US users for the first time. Unlike ECG and sleep apnea features, this capability is positioned as a wellness tool rather than a medical device and has not received full FDA clearance for diagnostic use. Users must calibrate the watch every 28 days using a standard blood pressure cuff for accurate readings.
Samsung has finally enabled blood pressure monitoring for Galaxy Watch users across the United States, addressing a feature that has been available in over 70 other countries for several years. Starting March 31, 2026, the company began a phased rollout of the capability through its Samsung Health Monitor app. This allows eligible users to measure and track their blood pressure directly from their wrist using compatible smartwatches.
The feature supports Galaxy Watch models from the Watch 4 series and newer, including the latest Galaxy Watch 8 and Watch 8 Classic, provided they run Wear OS 4.0 or higher. A paired Galaxy smartphone running Android 12 or above is also required. To ensure reliable results, users need to calibrate the watch initially and then every 28 days with a traditional upper arm blood pressure cuff. The system uses the watch’s optical sensors and pulse wave analysis to estimate blood pressure values based on the calibration data.
Samsung introduced blood pressure monitoring on its smartwatches back in 2020 and has gradually expanded it globally. In the US, regulatory considerations had delayed availability until now. The company emphasizes that this is intended for general wellness and fitness tracking purposes only, not for medical diagnosis or treatment. A future update planned for later in 2026 will add passive blood pressure trend monitoring to provide ongoing insights without manual measurements.
This development gives US consumers greater access to comprehensive health tracking on their Galaxy Watches, joining existing FDA cleared features such as ECG monitoring and sleep apnea detection. It reflects Samsung’s continued efforts to enhance wearable health capabilities while navigating different regulatory landscapes around the world.
“Select Galaxy Watch users in the U.S. can now conveniently monitor and track their blood pressure right from their wrist with help from Galaxy Watch and the Samsung Health Monitor app.”
By
HB Team
Related News
